The DOI matches its Crossref record; 241 of the 243 references it cites were found in a registry or an index.
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research
Open accessAbstract
Prostate cancer is a global cancer burden and considerable effort has been made through the years to identify biomarkers for the disease. Approximately a decade ago, the potential of analysing extracellular vesicles in liquid biopsies started to be envisaged. This was the beginning of a new exciting area of research investigating the rich molecular treasure found in extracellular vesicles to identify biomarkers for a variety of diseases. Vesicles released from prostate cancer cells and cells of the tumour microenvironment carry molecular information about the disease that can be analysed in several biological fluids. Numerous studies document the interest of researchers in this field of research. However, methodological issues such as the isolation of vesicles have been challenging. Remarkably, novel technologies, including those based on nanotechnology, show promise for the further development and clinical use of extracellular vesicles as liquid biomarkers. Development of biomarkers is a long and complicated process, and there are still not many biomarkers based on extracellular vesicles in clinical use. However, the knowledge acquired during the last decade constitutes a solid basis for the future development of liquid biopsy tests for prostate cancer. These are urgently needed to bring prostate cancer treatment to the next level in precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The challenge arises from the shared biomarkers and overlaps in size among the various EV subtypes [124].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [124]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–241 of 241
Standard PREanalytical Code Version 3.0
Betsou, F., Bilbao, R., Case, J., Chuaqui, R. F., Clements, J. A., Souza, Y. G. D., Wilde, A. D., Geiger, J., Grizzle, W. E., Guadagni, F., et al. (2018) · Biopreservation and Biobanking · doi:10.1089/bio.2017.0109 · Cited by 57
Scher, H. I., Armstrong, A. J., Schonhoft, J. D., Gill, A. J., Zhao, J. L., Barnett, E. S., Carbone, E. A., Lu, J., Antonarakis, E. S., Luo, J., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.02.042 · Cited by 56
Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer
Thompson, T. C., Timme, T. L., Li, L., & Goltsov, A. A. (1999) · APOPTOSIS · doi:10.1023/a:1009612708099 · Cited by 52
Santo, R. D., Romanò, S., Mazzini, A., Jovanović, S., Nocca, G., Campi, G., Papi, M., Spirito, M. D., Giacinto, F. D., & Ciasca, G. (2021) · Nanomaterials · doi:10.3390/nano11061476 · Cited by 52
Early detection of gastric cancer beyond endoscopy - new methods
Leja, M., & Linē, A. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101731 · Cited by 50
Wang, W. W., Sorokin, I., Aleksić, I., Fisher, H. A. �., Kaufman, R. P., Winer, A., McNeill, B., Gupta, R., Derya Tilki, A., Fleshner, N. E., et al. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000001020 · Cited by 49
Current clinical challenges in prostate cancer.
Silberstein, J. L., Pal, S. K., Lewis, B. E., & Sartor, O. A. (2013) · PubMed Central · doi:10.3978/j.issn.2223-4683.2013.09.03 · Cited by 46
Biomarkers for Prostate Cancer: Present Challenges and Future Opportunities
Sharma, P., Zargar‐Shoshtari, K., & Pow‐Sang, J. M. (2015) · Future Science OA · doi:10.4155/fso.15.72 · Cited by 46
Zapatero, A., Gómez‐Caamaño, A., Rodríguez, M. Á. C., Muinelo‐Romay, L., de Vidales, C. M., Abalo, A., Calvo, P., León‐Mateos, L., Olivier, C., & Vega‐Piris, L. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01577-5 · Cited by 46
Extracellular vesicles: Toward a clinical application in urological cancer treatment
Urabe, F., Kosaka, N., Kimura, T., Egawa, S., & Ochiya, T. (2018) · International Journal of Urology · doi:10.1111/iju.13594 · Cited by 45
Tonry, C. L., Finn, S. P., Armstrong, J., & Pennington, S. R. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09305-7 · Cited by 45
Review: Isolation and Detection of Tumor-Derived Extracellular Vesicles
Ziaei, P., Berkman, C. E., & Norton, M. G. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00267 · Cited by 45
Matsuzaki, K., Fujita, K., Tomiyama, E., Hatano, K., Hayashi, Y., Wang, C., Ishizuya, Y., Yamamoto, Y., Hayashi, T., Kato, T., et al. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-421 · Cited by 45
A five‐microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell‐free urine
Fredsøe, J., Rasmussen, A. K. I., Mouritzen, P., Borre, M., Orntoft, T. F., & Sørensen, K. D. (2019) · International Journal of Cancer · doi:10.1002/ijc.32296 · Cited by 44
Ishizuya, Y., Uemura, M., Narumi, R., Tomiyama, E., Koh, Y., Matsushita, M., Nakano, K., Hayashi, Y., Wang, C., Kato, T., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.084 · Cited by 44
Re, M. D., Crucitta, S., Sbrana, A., Rofi, E., Paolieri, F., Gianfilippo, G., Galli, L., Falcone, A., Morganti, R., Porta, C., et al. (2019) · British Journal of Urology · doi:10.1111/bju.14792 · Cited by 43
Management of Tamm–Horsfall Protein for Reliable Urinary Analytics
Xu, X., Barreiro, K. A., Musante, L., Kretz, O., Lin, H., Zou, H., Huber, T. B., & Holthöfer, H. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201900018 · Cited by 42
Danarto, R., Astuti, I., Umbas, R., & Haryana, S. M. (2019) · Urology Research and Practice · doi:10.5152/tud.2019.19163 · Cited by 42
Clinical significance of STEAP1 extracellular vesicles in prostate cancer
Khanna, K., Salmond, N., Lynn, K. S., Leong, H. S., & Williams, K. C. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00319-2 · Cited by 42
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
Connell, S. P., Hanna, M. Y., McCarthy, F., Hurst, R., Webb, M., Curley, H. M., Walker, H., Mills, R., Ball, R. Y., Sanda, M. G., et al. (2019) · British Journal of Urology · doi:10.1111/bju.14811 · Cited by 41
Kato, T., Mizutani, K., Kawakami, K., Fujita, Y., Ehara, H., & Ito, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04138 · Cited by 40
Research landscape of liquid biopsies in prostate cancer.
Campos‐Fernández, E., Barcelos, L. S., de Souza, A. G., Goulart, L. R., & Alonso‐Goulart, V. (2019) · PubMed Central · Cited by 37
Tian, S., Lei, Z., Gong, Z., Sun, Z., Xu, D., & Piao, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01508-0 · Cited by 37
Kohaar, I., Chen, Y., Banerjee, S., Borbiev, T., Kuo, H., Ali, A., Ravindranath, L., Kagan, J., Srivastava, S., Dobi, A. L., et al. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000001374 · Cited by 37
Goldkorn, A., Tangen, C. M., Plets, M., Morrison, G. J., Cunha, A. T., Xu, T., Pinski, J., Ingles, S. A., Triche, T. J., Harzstark, A. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3587 · Cited by 35
Platelet removal by single-step centrifugation
Rikkert, L. G., Coumans, F. A. W., Hau, C. M., Terstappen, L. W. M. M., & Nieuwland, R. (2020) · Platelets · doi:10.1080/09537104.2020.1779924 · Cited by 35
Ku, A. T., Fredsøe, J., Sørensen, K. D., Borre, M., Evander, M., Laurell, T., Lilja, H. G., & Ceder, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631021 · Cited by 34
Extracellular vesicles in prostate cancer: a narrative review
Hatano, K., & Fujita, K. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1210 · Cited by 31
Srinivasan, S., Duval, M. X., Kaimal, V., Cuff, C. A., & Clarke, S. H. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1684425 · Cited by 30
Khan, S., Simpson, J. S., Lynch, J. C., Turay, D., Mirshahidi, S., Gonda, A., Sanchez, T. W., Casiano, C. A., & Wall, N. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183122 · Cited by 29
Strati, A. D., Zavridou, M., Bournakis, E., Mastoraki, S., & Lianidou, E. S. (2019) · The Analyst · doi:10.1039/c9an00999j · Cited by 29
Fate of the Urinary Tract Virus BK Human Polyomavirus in Source-Separated Urine
Goetsch, H., Zhao, L., Gnegy, M., Imperiale, M. J., Love, N. G., & Wigginton, K. R. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02374-17 · Cited by 27
Wang, C., Zhang, Z., Chong, W., Luo, R., Myers, R. E., Gu, J. H., Lin, J., Wei, Q., Li, B., Rebbeck, T. R., et al. (2021) · Cancers · doi:10.3390/cancers13020268 · Cited by 24
The prostatic urethra as a Venturi effect urine-jet pump to drain prostatic fluid
Zaichick, V. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.04.006 · Cited by 23
Choi, J., Kim, S., Kwak, H., Park, D., Park, J., Ryu, J., Park, C., & Kang, J. (2017) · International Neurourology Journal · doi:10.5213/inj.1734961.458 · Cited by 22
Woo, J., Santasusagna, S., Banks, J., Pastor-Lopez, S., Yadav, K. K., Carceles‐Cordon, M., Dominguez-Andres, A., Den, R. B., Languino, L. R., Pippa, R., et al. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000001066 · Cited by 21
Ye, L., He, S., Wu, X., Jiang, S., Zhang, R., Yang, Z., Chen, F., Pan, D., Li, D., & Li, G. (2020) · Prostate Cancer · doi:10.1155/2020/3964615 · Cited by 16
Biomarkers for Diagnosis and Prognosis of Prostate Cancer
Rice, M. A., & Stoyanova, T. I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79726 · Cited by 14
Commercialized biomarkers: new horizons in prostate cancer diagnostics
Murphy, L., Prencipe, M., Gallagher, W. M., & Watson, R. W. G. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1011622 · Cited by 14
Extracellular vesicles in urological malignancies
Rimmer, M. P., Gregory, C. D., & Mitchell, R. T. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188570 · Cited by 11
Chung, J.-W., Kim, H. T., Ha, Y., Lee, E. H., Chun, S. Y., Lee, C., Byeon, K., Choi, S. H., Lee, J. N., Kim, B. S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250254 · Cited by 11
Research works printed but not linked: 1
- De Angelis G, Rittenhouse HG, Mikolajczyk SD. Blair Shamel, L., Semjonow, A. Twenty years of PSA: from prostate antigen to tumor marker. Rev Urol. 2007;9:113–23.
Cited by
Sorted by citations
Welsh, J. A., Goberdhan, D. C. I., O'Driscoll, L., Buzas, E. I., Blenkiron, C., Bussolati, B., Cai, H., Di Vizio, D., Driedonks, T. A. P., Erdbrügger, U., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12404 · Cited by 4,663
Self-citationLiquid biopsies: the future of cancer early detection
Connal, S., Cameron, J. M., Sala, A., Brennan, P. M., Palmer, D. S., Palmer, J. D., Perlow, H. K., & Baker, M. J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03960-8 · Cited by 403
Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis
Tran, H. L., Zheng, W., Issadore, D., Im, H., Cho, Y., Zhang, Y., Liu, D., Liu, Y., Li, B., Liu, F., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c00706 · Cited by 117
Cancer diagnosis using label-free SERS-based exosome analysis
Liu, Y., Li, M., Liu, H., Kang, C., & Wang, C. (2024) · Theranostics · doi:10.7150/thno.92621 · Cited by 107
Extracellular vesicles as personalized medicine
Beetler, D. J., Di Florio, D. N., Bruno, K. A., Ikezu, T., March, K. L., Cooper, L. T., Wolfram, J., & Fairweather, D. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101155 · Cited by 101
Metadata
- Authors
- Ramirez-Garrastacho, M., Bajo-Santos, C., Line, A., Martens-Uzunova, E. S., de la Fuente, J. M., Moros, M., Soekmadji, C., Tasken, K. A., & Llorente, A.
- Affiliations
- Latvian Biomedical Research and Study Centre (LV)
- The University of Queensland (AU)
- Oslo University Hospital (NO)
- Corresponding author
- Llorente, Alicia
- Venue
- British Journal of Cancer
- Published
- 2021-11-22
- Volume
- 126
- Issue
- 3
- Pages
- 331-350
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC8810769
- OpenAlex
- W3217233110
- Cited by
- 130
- References
- 243
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 36 · 2023: 29 · 2022: 13
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Zaguan (Universidad de Zaragoza) (submittedVersion, cc-by)
- Funders
- Latvijas Zinātnes Padome
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- extracellular vesicles, prostate cancer, liquid biopsy, tumor markers, vesicle isolation, tumor microenvironment, precision medicine
- MeSH terms
- Extracellular Vesicles, Cell-Free Nucleic Acids, Liquid Biopsy, Animals, Humans, Male, Neoplastic Cells, Circulating, Prostatic Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
